CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 103 enrolled
Drug / intervention
Lotrafilcon B multifocal contact lensdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01268501
NCT01268501N/ACompleted
CompareCT.gov

Clinical Assessment of a New Multifocal Contact Lens With Emmetropic Presbyopes

CIBA VISION·interventional·Posted Dec 31, 2010·Updated Jun 29, 2012

In Brief

A clinical study evaluating Lotrafilcon B multifocal contact lens for Presbyopia. Completed, enrolled 103 participants.

Detailed Summary

The purpose of this trial is to evaluate the use of multifocal contact lenses in people who use reading glasses only.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPresbyopia
Countries--
Collaborators--

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedDec 31, 2010
Enrollment StartDec 1, 2010
Primary CompletionFeb 1, 2011
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 15.5 years ago

Interventions

Lotrafilcon B multifocal contact lensdevice

Commercially marketed, silicone hydrogel, multifocal, soft contact lenses FDA-approved for up to 4 weeks recommended replacement schedule and up to 6 nights of extended (overnight) wear.